Reihenhaus in DAMAC Hills 2 (Akoya by DAMAC),Natura, 4 schlafzimmer, 2200000 AED - 16317330
Off-Plan|
Wiederverkauf
5
AED2.200.000
Geschätzte Zahlung AED 9,0 Tsd./Monat
Finanzierung prüfen
Natura, DAMAC Hills 2 (Akoya by DAMAC), Dubai
4 Schlafzimmer
5 Bäder
224 m²

Reihenhaus in DAMAC Hills 2 (Akoya by DAMAC),Natura, 4 schlafzimmer, 2200000 AED - 16317330

Casper Properties proudly presents this brand-new 4-bedroom G+2 townhouse in the
Natura Cluster, located within the rapidly growing community of DAMAC Hills 2.
Designed with modern living in mind, this spacious multi-level townhouse offers
a comfortable layout, contemporary finishes, and a family-friendly lifestyle. It
is an excellent choice for both end users and investors seeking a property with
strong future potential.
Property Details
4 spacious bedrooms
5 Bathrooms
Spacious Living & Dining area
Ideal for families
Modern finishes throughout
Located in a fast-growing community
Potential for strong rental demand

Community & Lifestyle
DAMAC Hills 2 is a master-planned residential community in Dubailand, offering
an affordable and family-oriented lifestyle surrounded by landscaped greenery
and a variety of outdoor amenities.
.
Residents can enjoy:
Malibu Beach and water attractions
Landscaped parks and open green spaces
Sports and fitness facilities
Jogging and cycling tracks
Retail outlets and community amenities
Family-friendly leisure and recreational

Get in touch with Casper Properties today for more information.

Objektinformationen

  • TypReihenhaus
  • ZweckZu verkaufen
  • Referenznr.Bayut - CP-DAMAC Hills 2-AGH
  • FertigstellungOff-Plan
  • MöblierungUnmöbliert
  • Hinzugefügt am27. August 2026
  • ÜbergabedatumQ2 2026

Validierte Informationen

Validated Check Mark Icon

Hypothek

Berechne und sieh dir die monatliche Hypothek für diese Reihenhaus an

Merkmale / Ausstattung

Balkon oder Terrasse
Schwimmbad
Zentralklimaanlage
Sicherheitspersonal

Projektinformationen

Validated Check Mark Icon

Vergleichbare Abschlüsse

Validated Check Mark Icon

Trends & Indizes

Regulatorische Informationen

Für Sie empfohlen